Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome

Diabetes

Volumn 53, Issue 8, 2004, Pages 2087-2094

  Carr, Darcy B ^a,c   Utzschneider, Kristina M ^b   Hull, Rebecca L ^b   Kodama, Keiichi ^b   Retzlaff, Barbara M ^b   Brunzell, John D ^b   Shofer, Jane B ^c   Fish, Brian E ^b   Knopp, Robert H ^b   Kahn, Steven E ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY FAT; CHOLESTEROL METABOLISM; CORONARY RISK; EDUCATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; NORMAL HUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ABDOMEN; ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; HUMANS; LIPOPROTEINS, HDL; METABOLIC SYNDROME X; MIDDLE AGED; PATIENT EDUCATION; PATIENT SELECTION; REFERENCE VALUES; TRIGLYCERIDES; WASHINGTON;

EID: 3242795814     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.8.2087     Document Type: Article

References (53)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
2. Ford E, Giles W, Dietz W: Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356-359, 2002
3. Alexander C, Landsman P, Teutsch S, Haffner S: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52:1210-1214, 2003
4. Lakka H-M, Laaksonen D, Lakka T, Niskanen L, Kumpusalo E, Tuomilehto J, Salonen J: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716, 2002
5. Laaksonen D, Lakka H-M, Niskanen L, Kaplan G, Salonen J, Lakka T: Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156:1070-1077, 2002
6. Ferrannini E, Haffner S, Mitchell B, Stern M: Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
7. Ferrannini E, Buzzigoli G, Bonadona R: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
8. Reaven G: Role of insulin resistance in human disease (Syndrome X): an expanded definition. Annu Rev Med 44:121-131, 1993
9. Reaven G: Role of insulin resistance in human disease. Diabetes 37:1495-1607, 1988
10. Carey D, Jenkins A, Campbell L, Freund J, Chisholm D: Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638, 1996
11. Cnop M, Landchild M, Vidal J, Havel P, Knowles N, Carr D, Wang F, Hull R, Boyko E, Retzlaff B, Walden C, Knopp R, Kahn S: The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51:1005-1015, 2002
12. Katsuki A, Sumida Y, Urakawa H, Gabazza E, Murashima S, Maruyama N, Morioka K, Nakatani K, Yano Y, Adachi Y: Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese, metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 26:2341-2344, 2003
13. Wagenknecht L, Langefeld C, Scherzinger A, Norris J, Haffner S, Saad M, Bergman R: Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 52:2490-2496, 2003
14. Fujimoto W, Abbate S, Kahn S, Hokanson J, Brunzell J: The visceral adiposity syndrome in Japanese-American men. Obes Res 2:364-371, 1994
15. Hayashi T, Boyko E, Leonetti D, McNeely M, Newell-Morris L, Kahn S, Fujimoto W: Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care 26:650-655, 2003
16. Rattarasarn C, Leelawattana R, Soonthornpun S, Setasuban W, Thamprasit A, Lim A, Chayanunnukul W, Thamkumpee N, Daendumrongsub T: Regional abdominal fat distribution in lean and obese Thai type 2 diabetic women: relationships with insulin sensitivity and cardiovascular risk factors. Metabolism 52:1444-1447, 2003
17. Kanai H, Tokunaga K, Fujioka S, Yamashita S, Kameda-Takemura K, Matsuzawa Y: Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women. Hypertension 27:125-129, 1996
18. Bacha F, Saad R, Gungor N, Janosky J, Arslanian S: Obesity, regional fat distribution, and Syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab 88:2534-2540, 2003
19. Carr M, Hokanson J, Deeb S, Purnell J, Mitchell E, Brunzell J: A hepatic lipase gene promotor polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women. Arterioscler Thromb Vasc Biol 19:2701-2707, 1999
20. Ribeiro-Filho F, Faria A, Kohlmann N, Zanella M-T, Ferreira S: Two-hour insulin determination improves the ability of abdominal fat measurement to identify risk for the metabolic syndrome. Diabetes Care 26:1725-1730, 2003
21. Pascot A, Despres JP, Lemieux I, Bergeron J, Nadeau A, Prud'homme D, Tremblay A, Lemieux S: Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance. Diabetologia 43:1126-1135, 2000
22. Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couillard C, Bergeron J, Lamarche B, Despres JP: Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 42:2007-2014, 2001
23. Nicklas B, Penninx B, Ryan A, Berman D, Lynch N, Dennis K: Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women. Diabetes Care 26:1413-1420, 2003
24. Nieves D, Cnop M, Retzlaff B, Walden C, Brunzell J, Knopp R, Kahn S: The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 52:172-179, 2003
25. Phillips G, Jing T, Heymsfield S: Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism 52:784-790, 2003
26. Lonnqvist F, Thome A, Nilsell K, Hoffstedt J, Arner P: A pathogenic role of visceral fat beta 3-adrenoreceptors in obesity. J Clin Invest 95:1109-1116, 1995
27. van Harmelen V, Dicker A, Ryden M, Hauner H, Lonnqvist F, Naslund E, Arner P: Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 51: 2029-2036, 2002
28. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S: Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52:1274-1278, 2003
29. Cnop M, Havel P, Utzschneider K, Carr D, Sinha M, Boyko E, Retzlaff B, Knopp R, Brunzell J, Kahn S: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459-469, 2003
30. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y: Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859-862, 1998
31. Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M: Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab 26:178-182, 2000
32. Alessi M, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46:860-867, 1997
33. Giltay EJ, Elbers JM, Gooren LJ, Emeis JJ, Kooistra T, Asscheman H, Stehouwer CD: Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. Arterioscler Thromb Vasc Biol 18:1716-1722, 1998
34. Knopp R, Retzlaff B, Fish B, Walden C, Wallick S, Anderson M, Aikawa K, Kahn S: Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding. Arterioscler Thromb Vasc Biol 23:1437-1443, 2003
35. Sjostrom L, Kvist H: Regional body fat measurements with CT scan and evaluation of anthropometric predictions. Acta Med Scand Suppl 723:169-177, 1988
36. Schwartz R, Shuman W, Larson V, Cain K, Fellingham G, Beard J, Kahn S, Stratton J, Cerqueira M, Abrass I: The effect of intensive endurance exercise training on body fat distribution in young and older men. Metabolism 40:545-551, 1991
37. Beard J, Bergman R, Ward W, Porte DJ: The insulin sensitivity index in nondiabetic man: correlations between clamp-derived and IVGTT-derived values. Diabetes 35:362-369, 1986
38. Bergman R, Ider Y, Bowden C, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677, 1979
39. Morgan D, Lazarow A: Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes 12:115-126, 1963
40. Zeger S, Liang K: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986
41. Diggle P, Liang K, Zeger S: Analysis of Longitudinal Data. New York, Oxford University Press, 1994
42. Sutton-Tyrrell K, Newman A, Simonsick E, Havlik R, Pahor M, Lakatta E, Spurgeon H, Vaitkevicius P: Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 38:429-433, 2001
43. Arad Y, Newstein D, Cadet F, Roth M, Guerci AD: Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol 21:2051-2058, 2001
44. Gabriely I, Ma X, Yang X, Atzmon G, Rajala M, Berg A, Scherer P, Rossetti L, Barzilai N: Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 51:2951-2958, 2002
45. Barzilai N, She L, Liu B-Q, Vuguin P, Cohen P, Wang J, Rossetti L. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 48:94-98, 1999
46. Brochu M, Tchernof A, Turner A, Ades P, Poehlman E: Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women? Metabolism 52:599-604, 2003
47. Boyko E, Fujimoto W, Leonetti D, Newell-Morris L: Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 23:465-471, 2000
48. Lamarche B, Lemieux S, Dagenais GR, Despres JP: Visceral obesity and the risk of ischaemic heart disease: insights from the Quebec Cardiovascular Study. Growth Horm IGF Res 8 (Suppl. B):1-8, 1998
49. St-Pierre J, Lemieux I, Vohl M, Perron P, Tremblay G, Despres J, Gaudet D: Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol 90:15-18, 2002
50. Fujimoto W, Bergstrom R, Boyko E, Chen K, Leonetti D, Newell-Morris L, Shofer J, Wahl P: Visceral adiposity and incident coronary heart disease in Japanese-American men: the 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 22:1808-1812, 1999
51. Drizd T, Dannenberg A, Engel A: Blood pressure levels in persons 18-74 years of age in 1976-1980, and trends in blood pressure from 1960 to 1980 in the United States. Vital and Health Statistics Series No. 11. PHS 86-1684. Hyattsville, MD, National Center for Health Statistics, 1986
52. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G: Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139:802-809, 2003
53. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Despres J: Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102:179-184, 2000